✦ LIBER ✦

S258 GABAPENTIN VS. PREGABALIN FOR THE TREATMENT OF NEUROPATHIC PAIN IN PATIENTS WITH SPINAL CORD INJURY: A CROSS-OVER STUDY

✍ Scribed by B. Yilmaz; E. Yasar; O. Koroglu Omac; A.S. Goktepe; A.K. Tan

Book ID: 118657490
Publisher: Wiley (John Wiley & Sons)
Year: 2011
Tongue: English
Weight: 57 KB
Volume: 5
Category: Article
ISSN: 1878-0075
DOI: 10.1016/s1754-3207(11)70824-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gabapentin for the treatment of spastici

Gabapentin for the treatment of spasticity in patients with spinal cord injury

✍ Gruenthal, M; Mueller, M; Olson, W L; Priebe, M M; Sherwood, A M; Olson, W H 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 270 KB

A 17-Week, Double-Blind, Placebo-Control

A 17-Week, Double-Blind, Placebo-Controlled Trial of Pregabalin for the Treatment of Neuropathic Pain Associated with Spinal Cord Injury: Analysis of Quantitative Assessment of Neuropathic Pain, Modified Brief Pain Inventory Interference Scale and Neuropathic Pain Symptom Inventory Scores

✍ Diana D. Cardenas; Bruce Parsons; Edward C. Nieshoff; Luis Sanin; Takehiko Kanek 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Chronic neuropathic pain management in s

Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous)

✍ N. Attal; G. Mazaltarine; B. Perrouin-Verbe; T. Albert 📂 Article 📅 2009 🏛 Elsevier 🌐 French ⚖ 454 KB

Chronic neuropathic pain management in s

Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous)

✍ N. Attal; G. Mazaltarine; B. Perrouin-Verbe; T. Albert 📂 Article 📅 2009 🏛 Elsevier 🌐 French ⚖ 454 KB

## Introduction: The pharmacological treatment of patients with spinal cord injury (sci) pain remains challenging despite new available drugs. such treatment should always be viewed in the context of global pain management in these patients. to date few clinical trials have been specifically devote